These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11336305)

  • 1. Enhanced osteoclast-like cell functions on nanophase ceramics.
    Webster TJ; Ergun C; Doremus RH; Siegel RW; Bizios R
    Biomaterials; 2001 Jun; 22(11):1327-33. PubMed ID: 11336305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced functions of osteoblasts on nanophase ceramics.
    Webster TJ; Ergun C; Doremus RH; Siegel RW; Bizios R
    Biomaterials; 2000 Sep; 21(17):1803-10. PubMed ID: 10905463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar healthy osteoclast and osteoblast activity on nanocrystalline hydroxyapatite and nanoparticles of tri-calcium phosphate compared to natural bone.
    MacMillan AK; Lamberti FV; Moulton JN; Geilich BM; Webster TJ
    Int J Nanomedicine; 2014; 9():5627-37. PubMed ID: 25506216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental research on the effect of nanophase ceramics on osteoblasts functions].
    Wen B; Chen Z; Jiang Y; Yang Z; Xu Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Jun; 22(3):463-7. PubMed ID: 16013237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific proteins mediate enhanced osteoblast adhesion on nanophase ceramics.
    Webster TJ; Ergun C; Doremus RH; Siegel RW; Bizios R
    J Biomed Mater Res; 2000 Sep; 51(3):475-83. PubMed ID: 10880091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The resorption of nanocrystalline calcium phosphates by osteoclast-like cells.
    Detsch R; Hagmeyer D; Neumann M; Schaefer S; Vortkamp A; Wuelling M; Ziegler G; Epple M
    Acta Biomater; 2010 Aug; 6(8):3223-33. PubMed ID: 20206720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporation of RANKL promotes osteoclast formation and osteoclast activity on β-TCP ceramics.
    Choy J; Albers CE; Siebenrock KA; Dolder S; Hofstetter W; Klenke FM
    Bone; 2014 Dec; 69():80-8. PubMed ID: 25245204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro osteoclast resorption of bone substitute biomaterials used for implant site augmentation: a pilot study.
    Taylor JC; Cuff SE; Leger JP; Morra A; Anderson GI
    Int J Oral Maxillofac Implants; 2002; 17(3):321-30. PubMed ID: 12074446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytocompatibility of nanophase hydroxyapatite ceramics].
    Wen B; Chen ZQ; Jiang YS; Yang ZW; Xu YZ
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Dec; 22(6):456-9. PubMed ID: 15656519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoblast adhesion on nanophase ceramics.
    Webster TJ; Siegel RW; Bizios R
    Biomaterials; 1999 Jul; 20(13):1221-7. PubMed ID: 10395391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The differential regulation of osteoblast and osteoclast activity by surface topography of hydroxyapatite coatings.
    Costa DO; Prowse PD; Chrones T; Sims SM; Hamilton DW; Rizkalla AS; Dixon SJ
    Biomaterials; 2013 Oct; 34(30):7215-26. PubMed ID: 23830579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of osteoclast-like cells on HA and TCP ceramics.
    Detsch R; Mayr H; Ziegler G
    Acta Biomater; 2008 Jan; 4(1):139-48. PubMed ID: 17723325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity.
    Collin-Osdoby P; Oursler MJ; Rothe L; Webber D; Anderson F; Osdoby P
    J Bone Miner Res; 1995 Jan; 10(1):45-58. PubMed ID: 7747630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human osteoclast and giant cell differentiation: the apparent switch from nonspecific esterase to tartrate resistant acid phosphatase activity coincides with the in situ expression of osteopontin mRNA.
    Connor JR; Dodds RA; James IE; Gowen M
    J Histochem Cytochem; 1995 Dec; 43(12):1193-201. PubMed ID: 8537635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polarized osteoclasts put marks of tartrate-resistant acid phosphatase on dentin slices--a simple method for identifying polarized osteoclasts.
    Nakayama T; Mizoguchi T; Uehara S; Yamashita T; Kawahara I; Kobayashi Y; Moriyama Y; Kurihara S; Sahara N; Ozawa H; Udagawa N; Takahashi N
    Bone; 2011 Dec; 49(6):1331-9. PubMed ID: 21983021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The surface microporosity of ceramic biomaterials influences the resorption capacity of osteoclasts.
    Zimmer G; Rohrhofer A; Lewis K; Goessl A; Hoffmann O
    J Biomed Mater Res A; 2013 Dec; 101(12):3365-71. PubMed ID: 23553950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid screening method for osteoclast differentiation in vitro that measures tartrate-resistant acid phosphatase 5b activity secreted into the culture medium.
    Alatalo SL; Halleen JM; Hentunen TA; Mönkkönen J; Väänänen HK
    Clin Chem; 2000 Nov; 46(11):1751-4. PubMed ID: 11067809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cytocompatibility and bending modulus of nanoceramic/polymer composites.
    McManus AJ; Doremus RH; Siegel RW; Bizios R
    J Biomed Mater Res A; 2005 Jan; 72(1):98-106. PubMed ID: 15538759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resorption of sintered synthetic hydroxyapatite by osteoclasts in vitro.
    Gomi K; Lowenberg B; Shapiro G; Davies JE
    Biomaterials; 1993; 14(2):91-6. PubMed ID: 8382090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoclast migration on phosphorylated osteopontin is regulated by endogenous tartrate-resistant acid phosphatase.
    Ek-Rylander B; Andersson G
    Exp Cell Res; 2010 Feb; 316(3):443-51. PubMed ID: 19854170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.